Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Meissner

Showing results (351-360 of 436) with videos related to

Pageof 44
Sort By:
Plos Pathogens|August 29, 2007
V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodiesMeg M Laakso, Fang-Hua Lee, Beth Haggarty, et al.
BMC Neurology|June 13, 2026
Natural history and 12-month progression of multiple system atrophy in a Chinese cohortTao Feng, Han Wang, Jian Wang, et al.
Neurobiology of Disease|May 19, 2015
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker InitiativeBrice Laurens, Radu Constantinescu, Roy Freeman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2026
Plasma p-tau217 Versus p-tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease-Related Neurostructural Changes and Cognitive FunctionEleonora Fiorenzato, Simone Cauzzo, Giulia Musso, et al.
Frontiers in Neurology|September 2, 2025
Detecting amyloid and tau pathology in Parkinson's disease, 4R-tauopathies and control subjects with plasma pTau217Giulia Musso, Eleonora Fiorenzato, Valentina Misenti, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Development of CXCR3 antagonists. Part 4: discovery of 2-amino-(4-tropinyl)quinolinesRoland L Knight, Daniel R Allen, Helen L Birch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2025
Deep Learning to Differentiate Parkinsonian Syndromes Using Multimodal Magnetic Resonance Imaging: A Proof-of-Concept StudyGiulia Maria Mattia, Lydia Chougar, Alexandra Foubert-Samier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2025
Reply to: Deep Learning to Differentiate Parkinsonian Syndromes: From Proof of Concept to Clinical TrustGiulia Maria Mattia, Lydia Chougar, Alexandra Foubert-Samier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 7, 2023
Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging StudyFlorian Krismer, Patrice Péran, Vincent Beliveau, et al.
The Journal of Infectious Diseases|May 13, 2017
Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral TherapyZhenwu Luo, Zhen Li, Lisa Martin, et al.
Pageof 44

Showing results (351-360 of 436) with videos related to

Sort By:
Pageof 44
Plos Pathogens|August 29, 2007
V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodiesMeg M Laakso, Fang-Hua Lee, Beth Haggarty, et al.
BMC Neurology|June 13, 2026
Natural history and 12-month progression of multiple system atrophy in a Chinese cohortTao Feng, Han Wang, Jian Wang, et al.
Neurobiology of Disease|May 19, 2015
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker InitiativeBrice Laurens, Radu Constantinescu, Roy Freeman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2026
Plasma p-tau217 Versus p-tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease-Related Neurostructural Changes and Cognitive FunctionEleonora Fiorenzato, Simone Cauzzo, Giulia Musso, et al.
Frontiers in Neurology|September 2, 2025
Detecting amyloid and tau pathology in Parkinson's disease, 4R-tauopathies and control subjects with plasma pTau217Giulia Musso, Eleonora Fiorenzato, Valentina Misenti, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Development of CXCR3 antagonists. Part 4: discovery of 2-amino-(4-tropinyl)quinolinesRoland L Knight, Daniel R Allen, Helen L Birch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2025
Deep Learning to Differentiate Parkinsonian Syndromes Using Multimodal Magnetic Resonance Imaging: A Proof-of-Concept StudyGiulia Maria Mattia, Lydia Chougar, Alexandra Foubert-Samier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2025
Reply to: Deep Learning to Differentiate Parkinsonian Syndromes: From Proof of Concept to Clinical TrustGiulia Maria Mattia, Lydia Chougar, Alexandra Foubert-Samier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 7, 2023
Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging StudyFlorian Krismer, Patrice Péran, Vincent Beliveau, et al.
The Journal of Infectious Diseases|May 13, 2017
Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral TherapyZhenwu Luo, Zhen Li, Lisa Martin, et al.
Pageof 44